Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

IDEXX LABORATORIES DANMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.9% 0.9% 0.7% 1.0% 1.2% 1.3% 8.5% 8.4%   Credit score (0-100)   92 91 94 84 81 78 29 29   Credit rating   A A AA A A A BB BB   Credit limit (kDKK)   1,355.7 1,392.1 1,902.0 1,073.4 173.6 328.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,148 6,222 6,487 8,443 9,540 8,007 0.0 0.0   EBITDA   1,488 1,378 1,400 1,708 2,026 1,800 0.0 0.0   EBIT   1,437 1,336 1,384 1,693 2,016 1,789 0.0 0.0   Pre-tax profit (PTP)   1,380.3 1,273.0 1,297.3 1,601.5 1,916.3 16,237.9 0.0 0.0   Net earnings   1,046.4 1,055.6 1,160.3 1,602.7 1,454.7 16,665.1 0.0 0.0   Pre-tax profit without non-rec. items   1,380 1,273 1,297 1,602 1,916 1,803 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   942 513 204 255 233 23.3 0.0 0.0   Shareholders equity total   10,141 11,197 12,357 13,960 125 16,790 16,665 16,665   Interest-bearing liabilities   4,941 3,414 6,000 19,050 3,139 6,582 0.0 0.0   Balance sheet total (assets)   19,467 18,201 22,415 27,351 22,052 28,030 16,665 16,665   Net Debt   -6,216 -6,136 -6,973 7,454 -7,719 -7,106 -16,665 -16,665     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,148 6,222 6,487 8,443 9,540 8,007 0.0 0.0   Gross profit growth   -22.4% 20.9% 4.3% 30.2% 13.0% -16.1% -100.0% 0.0%   Employees   6 0 7 9 6 8 0 0   Employee growth %   -14.3% -100.0% 0.0% 28.6% -33.3% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,467 18,201 22,415 27,351 22,052 28,030 16,665 16,665   Balance sheet change%   13.4% -6.5% 23.2% 22.0% -19.4% 27.1% -40.5% 0.0%   Added value   1,488.2 1,378.0 1,399.8 1,708.4 2,031.3 1,799.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -396 -471 -325 36 -32 -220 -23 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.9% 21.5% 21.3% 20.1% 21.1% 22.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.9% 7.1% 6.8% 6.8% 8.2% 7.1% 0.0% 0.0%   ROI %   11.0% 8.9% 8.4% 6.6% 7.8% 8.5% 0.0% 0.0%   ROE %   10.9% 9.9% 9.9% 12.2% 20.7% 197.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.8% 61.5% 55.1% 51.0% 0.6% 59.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -417.7% -445.3% -498.1% 436.3% -381.0% -394.9% 0.0% 0.0%   Gearing %   48.7% 30.5% 48.6% 136.5% 2,510.8% 39.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.7% 1.5% 1.8% 0.7% 0.9% -0.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 2.4 2.1 1.9 3.0 2.3 0.0 0.0   Current Ratio   2.0 2.4 2.1 1.9 3.0 2.3 0.0 0.0   Cash and cash equivalent   11,157.4 9,550.0 12,973.0 11,595.8 10,857.3 13,687.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   8,934.5 9,944.2 10,608.6 11,952.4 12,975.9 14,511.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   248 0 200 190 339 225 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   248 0 200 190 338 225 0 0   EBIT / employee   240 0 198 188 336 224 0 0   Net earnings / employee   174 0 166 178 242 2,083 0 0